SLC5A2 and amyloidosis: 59 OMeara OMeara E E McDonald McDonald M M Chan Chan M M CCS/CHFS Heart Failure Guidelines Clinical Trial Update on functional mitral regurgitation, SGLT2 inhibitors, ARNI in HFpEF, and tafamidis in Amyloidosis CCS/CHFS Heart Failure Guidelines Clinical Trial Update on functional mitral regurgitation, SGLT2 inhibitors, ARNI in HFpEF, and tafamidis in Amyloidosis Canadian Journal of Cardiology Canadian Journal of Cardiology 2020 2020 36 36 159 159 169 169 32036861 32036861